Google
ABT 株価分析 — ABBOTT LABORATORIES (Healthcare >> Medical Devices)
ABT に関するよくある質問
ABTのPER（株価収益率）は？
ABBOTT LABORATORIES（ABT）は現在PER 33.69倍で取引されています。
ABTのROE（自己資本利益率）は？
ABBOTT LABORATORIESのROEは10.61%です。
ABTの配当利回りは？
ABBOTT LABORATORIESの配当利回りは2.30%です。
ABTの品質スコア（Quality Score）は？
当社のAIはABTの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
ABTは今が買い時ですか？
当社AIのタイミングスコアは100点中87点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
ABTはどのセクターに属しますか？
ABBOTT LABORATORIESはHealthcare >> Medical Devicesセクターに分類されます（NYSE市場）
ABT AI Analysis Summary
Our AI summary for ABT: ABBOTT LABORATORIES (NYSE), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 33.69, ROE of 10.61%, a dividend yield of 2.30%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 87/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 105.70
Price
0.09
(0.09%)
Day Change
|
|
|---|
ABT, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROAがROEに比べて低い
ROAの伸びが低い
Last-year ROA is lower than last-2-years ROA.
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not quite good , and ability to make profit is ok , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.12 From 30 days period |
| News Score | N/A |
| Magic Formula Rank by ROA |
1652
|
| Magic Formula Rank by ROE |
1652
|
| Magic Formula Rank by ROIC |
1910
|
| Price | 105.70 |
| PBV / Sector |
3.53 / -101.57
|
| Earning Per Share | 3.14 |
| PE / Sector |
33.69 / 31.23
|
| PEG or PE/Growth / Sector |
1.52 / 0.40
|
| Average 1M Daily Value |
1,074.84 M
GREAT
|
| Average 1W Daily Value |
1,009.31 M
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
54% |
| ポイントになる統計 |
|
66% |
| 配当 |
|
41% |
| 登録情報 |
| Analyze Date | 2026-08-01 07:59:25 |
| Symbol | ABT |
| Name | ABBOTT LABORATORIES |
| Sector | Healthcare >> Medical Devices |
| Market | NYSE |
| Listed Shares | 1,730.38 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 182,745.79 / 20,104.97 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400
Phone: 224 667 6100
Website: https://www.abbott.com
Employees: 122,000
Sector: Healthcare >> Medical Devices
Description: Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
